Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ustekinumab MeSH Descriptor Data 2025


MeSH Heading
Ustekinumab
Tree Number(s)
D12.776.124.486.485.114.224.060.937
D12.776.124.790.651.114.224.060.937
D12.776.377.715.548.114.224.200.937
Unique ID
D000069549
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069549
Scope Note
A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.
Entry Term(s)
CNTO 1275
CNTO-1275
Stelara
Pharm Action
Dermatologic Agents
Registry Numbers
FU77B4U5Z0
0
See Also
Interleukin-12
Interleukin-23
Public MeSH Note
2016; USTEKINUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2011-2015; and under ANTIBODIES, MONOCLONAL 2005-2011
History Note
2016 (2005)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2017/06/20
Ustekinumab Preferred
CNTO 1275 Narrower
Stelara Narrower
page delivered in 0.154s